» Articles » PMID: 36557671

Environmental Neurotoxin β--Methylamino-L-alanine (BMAA) As a Widely Occurring Putative Pathogenic Factor in Neurodegenerative Diseases

Overview
Journal Microorganisms
Specialty Microbiology
Date 2022 Dec 23
PMID 36557671
Authors
Affiliations
Soon will be listed here.
Abstract

In the present review we have discussed the occurrence of β--methylamino-L-alanine (BMAA) and its natural isomers, and the organisms and sample types in which the toxin(s) have been detected. Further, the review discusses general pathogenic mechanisms of neurodegenerative diseases, and how modes of action of BMAA fit in those mechanisms. The biogeography of BMAA occurrence presented here contributes to the planning of epidemiological research based on the geographical distribution of BMAA and human exposure. Analysis of BMAA mechanisms in relation to pathogenic processes of neurodegeneration is used to critically assess the potential significance of the amino acid as well as to identify gaps in our understanding. Taken together, these two approaches provide the basis for the discussion on the potential role of BMAA as a secondary factor in neurodegenerative diseases, the rationale for further research and possible directions the research can take, which are outlined in the conclusions.

Citing Articles

Copper toxicity and deficiency: the vicious cycle at the core of protein aggregation in ALS.

Min J, Sarlus H, Harris R Front Mol Neurosci. 2024; 17:1408159.

PMID: 39050823 PMC: 11267976. DOI: 10.3389/fnmol.2024.1408159.


Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy.

Sini P, Galleri G, Ciampelli C, Galioto M, Padedda B, Luglie A Front Immunol. 2024; 15:1360068.

PMID: 38596666 PMC: 11002123. DOI: 10.3389/fimmu.2024.1360068.


Neurotoxic non-protein amino acids in commercially harvested Lobsters (Homarus americanus H. Milne-Edwards).

Sandhu P, Solonenka J, Murch S Sci Rep. 2024; 14(1):8017.

PMID: 38580836 PMC: 10997655. DOI: 10.1038/s41598-024-58778-1.


Freshwater Cyanobacterial Toxins, Cyanopeptides and Neurodegenerative Diseases.

Nugumanova G, Ponomarev E, Askarova S, Fasler-Kan E, Barteneva N Toxins (Basel). 2023; 15(3).

PMID: 36977124 PMC: 10057253. DOI: 10.3390/toxins15030233.

References
1.
Li A, Song J, Hu Y, Deng L, Ding L, Li M . New Typical Vector of Neurotoxin β-N-Methylamino-l-Alanine (BMAA) in the Marine Benthic Ecosystem. Mar Drugs. 2016; 14(11). PMC: 5128745. DOI: 10.3390/md14110202. View

2.
Cicero C, Mostile G, Vasta R, Rapisarda V, Signorelli S, Ferrante M . Metals and neurodegenerative diseases. A systematic review. Environ Res. 2017; 159:82-94. DOI: 10.1016/j.envres.2017.07.048. View

3.
Dulic T, Svircev Z, Palanacki Malesevic T, Faassen E, Savela H, Hao Q . Assessment of Common Cyanotoxins in Cyanobacteria of Biological Loess Crusts. Toxins (Basel). 2022; 14(3). PMC: 8953721. DOI: 10.3390/toxins14030215. View

4.
Waseem R, Shamsi A, Kazim S, Islam A . An Insight Into Mitochondrial Dysfunction and its Implications in Neurological Diseases. Curr Drug Targets. 2021; 22(14):1585-1595. DOI: 10.2174/1389450121999201230204050. View

5.
Nunn P, Ponnusamy M . Beta-N-methylaminoalanine (BMAA): metabolism and metabolic effects in model systems and in neural and other tissues of the rat in vitro. Toxicon. 2009; 54(2):85-94. DOI: 10.1016/j.toxicon.2009.03.008. View